Cytomegalovirus DNA concentration in plasma predicts development of cytomegalovirus disease in kidney transplant recipients
- 1 July 2002
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 8 (7) , 431-434
- https://doi.org/10.1046/j.1469-0691.2002.00449.x
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- A PROSPECTIVE STUDY OF THE NATURAL COURSE OF CYTOMEGALOVIRUS INFECTION AND DISEASE IN RENAL ALLOGRAFT RECIPIENTS1Transplantation, 2000
- Comparison of Quantitative Cytomegalovirus (CMV) PCR in Plasma and CMV Antigenemia Assay: Clinical Utility of the Prototype AMPLICOR CMV MONITOR Test in Transplant RecipientsJournal of Clinical Microbiology, 2000
- Immunologic Parameters as Predictive Factors of Cytomegalovirus Disease in Renal Allograft RecipientsThe Journal of Infectious Diseases, 1999
- Quantity of human cytomegalovirus (CMV) DNAemia as a risk factor for CMV disease in renal allograft recipients: Relationship with donor/recipient CMV serostatus, receipt of augmented methylprednisolone and antithymocyte globulin (ATG)Journal of Medical Virology, 1999
- Quantitative Polymerase Chain Reaction to Predict Occurrence of Symptomatic Cytomegalovirus Infection and Assess Response to Ganciclovir Therapy in Renal Transplant RecipientsThe Journal of Infectious Diseases, 1998
- In vitro generation of human cytomegalovirus pp65 antigenemia, viremia, and leukoDNAemia.Journal of Clinical Investigation, 1998
- Diagnosis of cytomegalovirus infection in kidney transplant recipients by a quantitative RNA-DNA hybrid capture assay for cytomegalovirus DNA in leukocytesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1998